EU conference 'The Microbial Threat'.

[1]  I. Gyssens,et al.  Improving the quality of antimicrobial drug use can result in cost containment , 1995, Pharmacy World and Science.

[2]  R. Wise.  Science, medicine, and the future , 1998 .

[3]  F. Aarestrup,et al.  The association between the use of antimicrobial growth promoters and development of resistance in pathogenic bacteria towards growth promoting and therapeutic antimicrobials , 1998 .

[4]  M. Glynn,et al.  Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States. , 1998, The New England journal of medicine.

[5]  B. Balkau,et al.  Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. , 1998, JAMA.

[6]  S. Bronzwaer,et al.  A SURVEILLANCE SYSTEM FOR EUROPE , 1998 .

[7]  J. Wain,et al.  Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. Swartz.  Use of antimicrobial agents and drug resistance. , 1997, The New England journal of medicine.

[9]  P Huovinen,et al.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. , 1997, The New England journal of medicine.

[10]  R. Moellering,et al.  Antimicrobial-drug resistance. , 1996, The New England journal of medicine.

[11]  G. Stefánsdóttir,et al.  Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study , 1996, BMJ.

[12]  J. Fung,et al.  Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  R. Weinstein,et al.  Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit. , 1996, Infection control and hospital epidemiology.

[14]  J. Meer,et al.  Optimizing antimicrobial therapy. A method for antimicrobial drug use evaluation. , 1992, The Journal of antimicrobial chemotherapy.

[15]  Mitchell L. Cohen.  Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era , 1992, Science.

[16]  H. Endtz,et al.  Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. , 1991, The Journal of antimicrobial chemotherapy.

[17]  H. Gaya,et al.  Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients , 1986, Antimicrobial Agents and Chemotherapy.

[18]  W. Witte,et al.  Spread of plasmid‐mediated nourseothricin resistance due to antibiotic use in animal husbandry , 1986, Journal of basic microbiology.

[19]  E. Tietze,et al.  Plasmid-borne streptothricin resistance in gram-negative bacteria. , 1984, Plasmid.